Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Blood|October 15, 1994
Pharmacokinetic and antithrombotic properties of two pentasaccharides with high affinity to antithrombin III in the rabbit: comparison with CY216D Carrie, C Caranobe, S Saivin, et al.Thrombosis and Haemostasis|August 1, 1994
Pharmacological properties of CY 216 and of its ACLM and BCLM components in the rabbitV Peyrou, J C Lormeau, C Caranobe, et al.Arzneimittel-Forschung|August 31, 2000
Determination of trimebutine and desmethyl-trimebutine in human plasma by HPLCM Lavit, S Saivin, H Boudra, et al.Leukemia|June 1, 1993
Effects of H-7 and staurosporine on proliferation and self-renewal of acute myeloid leukemia progenitorsJ Laredo, C Demur, C Muller, et al.Blood|September 1, 1992
Sensitivity of fresh acute myeloid leukemia cells to etoposide: relationship with cell growth characteristics and DNA single-strand breaksM Chiron, C Demur, V Pierson, et al.Arzneimittel-Forschung|May 1, 1993
Pharmacokinetic and pharmacodynamic study of amodiaquine and its two metabolites after a single oral dose in human volunteersF Laurent, S Saivin, P Chretien, et al.International Journal of Clinical Pharmacology and Therapeutics|April 10, 2008
Cefepime in intensive care unit patients: validation of a population pharmacokinetic approach and influence of covariablesB Georges, J-M Conil, T Seguin, et al.International Journal of Clinical Pharmacology and Therapeutics|August 27, 2005
Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimenB Georges, J M Conil, P Cougot, et al.International Journal of Antimicrobial Agents|August 16, 2006
Increased amikacin dosage requirements in burn patients receiving a once-daily regimenJ M Conil, B Georges, A Breden, et al.Pathologie-Biologie|July 27, 1999
[Continuous versus intermittent cefepime infusion in critical care. Preliminary results]B Georges, M Archambaud, S Saivin, et al.Pageof 6